NEW YORK, NY, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Scientists at the Tisch Multiple Sclerosis Research Center ...
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life. : To examine ...
Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 decades. With more than 20 FDA-approved therapies now available, clinicians ...
Experts in MS discuss the evolution in treatment options over time and the shift towards use of early high-efficacy therapy. Neil Minkoff, MD: As someone who’s been involved in medication management, ...
March is MS Awareness Month, a nationwide campaign raising awareness about the chronic disease that affects 2.9 million people worldwide. IMSMP and Tisch MSRCNY serve as an example of the laboratory ...
Multiple sclerosis (MS) is an insidious disease. Patients suffer because their immune system is attacking their own nerve fibres, which inhibits the transmission of nerve signals. People with MS ...
Pre-pregnancy and pregnancy planning for women with MS can lead to treatment changes that may affect risk of relapse. Combining preconception, gestation, and postpartum periods, pregnancy raised ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results